RTW Biotech Opportunities (LON:RTW – Get Free Report) shares rose 1% during trading on Thursday . The company traded as high as GBX 2.12 and last traded at GBX 2.09. Approximately 164,628 shares traded hands during mid-day trading, a decline of 71% from the average daily volume of 559,437 shares. The stock had previously closed at GBX 2.07.
RTW Biotech Opportunities Price Performance
The stock has a 50 day simple moving average of GBX 2.15 and a 200-day simple moving average of GBX 1.79. The firm has a market cap of £6.82 million, a PE ratio of -0.08 and a beta of 0.60.
RTW Biotech Opportunities Company Profile
RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives. RTW Bio is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
Read More
- Five stocks we like better than RTW Biotech Opportunities
- Free: The Crypto Summit That Could Change Your Life
- Think You Missed Silver? You’re Wrong. Here’s Why.
- Your Bank Account Is No Longer Safe
- When to buy gold (mathematically)
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
